SE8305467L - 1,4-dihydropyridinderivat - Google Patents

1,4-dihydropyridinderivat

Info

Publication number
SE8305467L
SE8305467L SE8305467A SE8305467A SE8305467L SE 8305467 L SE8305467 L SE 8305467L SE 8305467 A SE8305467 A SE 8305467A SE 8305467 A SE8305467 A SE 8305467A SE 8305467 L SE8305467 L SE 8305467L
Authority
SE
Sweden
Prior art keywords
carbon atoms
nitratoalkyl
compounds
artery disease
dihydropyridine
Prior art date
Application number
SE8305467A
Other languages
English (en)
Other versions
SE440648B (sv
SE8305467D0 (sv
Inventor
K Hatayama
A Nakazato
T Ogawa
S Ito
J Sawada
Original Assignee
Taisho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taisho Pharmaceutical Co Ltd filed Critical Taisho Pharmaceutical Co Ltd
Publication of SE8305467D0 publication Critical patent/SE8305467D0/sv
Publication of SE8305467L publication Critical patent/SE8305467L/sv
Publication of SE440648B publication Critical patent/SE440648B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/02Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SE8305467A 1982-04-22 1983-10-05 1,4-dihydropyridin-dikarboxylsyra-nitratoalkylestrar SE440648B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP57067759A JPS58185562A (ja) 1982-04-22 1982-04-22 1,4−ジヒドロピリジン誘導体

Publications (3)

Publication Number Publication Date
SE8305467D0 SE8305467D0 (sv) 1983-10-05
SE8305467L true SE8305467L (sv) 1985-04-06
SE440648B SE440648B (sv) 1985-08-12

Family

ID=13354183

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8305467A SE440648B (sv) 1982-04-22 1983-10-05 1,4-dihydropyridin-dikarboxylsyra-nitratoalkylestrar

Country Status (8)

Country Link
US (1) US4472411A (sv)
EP (1) EP0092936B1 (sv)
JP (1) JPS58185562A (sv)
AU (1) AU565424B2 (sv)
BE (1) BE898024A (sv)
DE (1) DE3370620D1 (sv)
NL (1) NL8303616A (sv)
SE (1) SE440648B (sv)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3244178A1 (de) * 1982-11-30 1984-05-30 Bayer Ag, 5090 Leverkusen 1,4-dihydropyridinderivate, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
GB8314744D0 (en) * 1983-05-27 1983-07-06 Fujisawa Pharmaceutical Co 2 6-disubstituted-1 4-dihydropyridine derivative
EP0127150A3 (en) * 1983-05-27 1987-07-22 Fujisawa Pharmaceutical Co., Ltd. 2,6-disubstituted-1,4-dihydropyridine derivative, process for the preparation of the same and pharmaceutical composition comprising the same
JPS60156671A (ja) * 1984-01-25 1985-08-16 Yamanouchi Pharmaceut Co Ltd ジヒドロピリジン誘導体およびその製造法
US4730052A (en) * 1984-07-13 1988-03-08 Taisho Pharmaceutical Co., Ltd. Method for preparing unsymmetrical 1,4-dihydropyridine-3,5-dicarboxylic acid diesters
ES8708211A1 (es) 1985-06-14 1987-10-01 Sankyo Co Un procedimiento para la preparacion de nuevos derivados de 4-(fenil sustituido)-1,4-dihidropiridina.
JPS62174050A (ja) * 1985-10-21 1987-07-30 Nippon Shoji Kk 3−アミノカルボニル−1,4−ジヒドロピリジン−5−カルボン酸誘導体、その製法および医薬組成物
US4780538A (en) * 1986-02-12 1988-10-25 Merck & Co., Inc. Process for 1,4-dihydropyridine compounds using a titanamine catalyst
JPS62292757A (ja) * 1986-06-12 1987-12-19 Taisho Pharmaceut Co Ltd 1,4−ジヒドロピリジン誘導体
JPS6396126A (ja) * 1986-10-13 1988-04-27 Taisho Pharmaceut Co Ltd 安定化組成物
US5047543A (en) * 1988-11-24 1991-09-10 Taisho Pharmaceutical Co., Ltd. 1,4-dihydropyridine derivatives
NL9001752A (nl) * 1990-08-02 1992-03-02 Cedona Pharm Bv Nieuwe 1,4-dihydropyridinederivaten.
AU2002322720B2 (en) 2001-07-25 2008-11-13 Raptor Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
CN102379684B (zh) 2005-04-28 2014-11-19 普罗透斯数字保健公司 药物信息系统
KR20090071598A (ko) 2006-09-18 2009-07-01 랩터 파마슈티컬 인코포레이티드 수용체 결합 단백질(rap)-접합체 투여에 의한 간 질환의 치료
EP2398500B1 (en) 2009-02-20 2019-03-13 2-BBB Medicines B.V. Glutathione-based drug delivery system
ES2942923T3 (es) 2009-05-06 2023-06-07 Laboratory Skin Care Inc Composiciones de administración dérmica que comprenden complejos de agente activo-partículas de fosfato de calcio y métodos de uso de las mismas
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1670827C3 (de) * 1967-03-20 1974-10-24 Bayer Ag, 5090 Leverkusen 4-(2'-Nitrophenyl)-2,6-dimethyl-3,5-dicarbmethoxy-1,4-dihydropyridin
DE2117573C3 (de) * 1971-04-10 1978-07-27 Bayer Ag, 5090 Leverkusen Verfahren zur Herstellung von unsymmetrischen l,4-Dihydropyridin-3,5dicarbonsäureestern, sowie ihre Verwendung als Arzneimittel
DE2847236A1 (de) * 1978-10-31 1980-05-14 Bayer Ag Neue dihydropyridine mit substituierten estergruppierungen, mehrer verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel

Also Published As

Publication number Publication date
EP0092936A1 (en) 1983-11-02
US4472411A (en) 1984-09-18
AU1994183A (en) 1985-04-18
DE3370620D1 (en) 1987-05-07
SE440648B (sv) 1985-08-12
JPS58185562A (ja) 1983-10-29
BE898024A (fr) 1984-04-19
JPS635024B2 (sv) 1988-02-01
EP0092936B1 (en) 1987-04-01
SE8305467D0 (sv) 1983-10-05
AU565424B2 (en) 1987-09-17
NL8303616A (nl) 1985-05-17

Similar Documents

Publication Publication Date Title
SE8305467D0 (sv) 1,4-dihydropyridinderivat
IL116122A0 (en) Intermediates to heterocyclic-cyclic amine derivatives
DE122006000010I1 (de) Benzocyclobutyl- oder Indanyl-Alkyl-Amino-Alkyl substituierte 3- Benzazepin-2-ones, verwendbar in der Behandlung von kardiovaskularen Krankheiten
KR890701107A (ko) 알쯔하이머 병 치료용 화합물들
ES515081A0 (es) "procedimiento para la preparacion de derivados de 6-metilprednisolona".
FI822203L (fi) Nya 2-aryl-3,4-diaza-bicyklo/4,n,0/-alken-(2)-oner-(5), foerfarande foer deras framstaellning och dessa innehaollande laekemedel
DK163287D0 (da) 1,4-diazepiner og farmaceutiske midler med indhold af saadanne forbindelser
FR2387988A1 (fr) Esters de cefuroxime, leur preparation et leur application therapeutique
IT1130561B (it) Procedimento per il trattamento d'olio greggio
NO891703L (no) Farmasoeytiske sammensetninger for behandling av psoriasis.
FR2384745A1 (fr) Derives de la somatostatine et leur preparation
FR2389594A1 (sv)
NZ217418A (en) Tricyclic heterocyclic compounds and pharmaceutical compositions
FI830397A0 (fi) Foerfarande foer framstaellning av imidazolidinderivat
RU1833365C (ru) Cпocoб пoлучehия tpииoдбehзoльhыx coeдиhehий
FR2387215A1 (fr) 4-alcoylthio-2-trifluoromethylalcanesulfonanilides et leurs derives
FR2389597A1 (sv)
DE3460834D1 (en) Derivatives of bicyclo(4.2.0)octatriene-1,3,5, their preparation and their therapeutical application
FR2389615A1 (sv)
NO842345L (no) Heksahydropyrrolo(2,1-a)isoquinolin-derivater.
FR2381008A1 (fr) Nouveaux patchoulols hydroxyles
NO811185L (no) Fremgangsmaate for fremstilling av farmakologisk aktive tiazolderivater.
FR2428041A1 (fr) Derives d'esters d'acides quinolopyranne-4-one-2-carboxyliques et application de ceux-ci comme antiasthmatiques antiallergiques
DK416289A (da) Estere af 3-demethylthiocolchicin og n-acylanaloger
FR2481697B1 (sv)

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8305467-6

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8305467-6

Format of ref document f/p: F